Opinion ID: 1476714
Heading Depth: 1
Heading Rank: 3

Heading: The Contaminated Pluri-B

Text: According to the stipulation, a number of vials with labels, which form the subject-matter of Count VII, were shipped by the appellants on June 18, 1946, to Dr. P. M. Ryerson, Phoenix, Arizona. The vials contained Pluri-B, and, according to the labels, the contents were for intramuscular or intravenous use. On or about July 12, 1946, Maurice P. Kerr, an inspector for the Administration, collected a sample consisting of six vials and their contents, each at random from different boxes of the shipment in Dr. Ryerson's possession. The inspector marked the labels, sealed the vials with official seals, and forwarded them by express to the Administration at Washington. Dr. Frank H. Wiley, chief of the chemical section of the medical division of the Administration, holding a doctor's degree in biochemistry, testified that he received the sample on July 23, 1946. He put the vials up to a light and found with the naked eye that all six of them were very badly contaminated with undissolved material. Dr. Wiley was asked the following hypothetical question, which the appellants assert was bad and improper because it did not include a sufficient factual basis to support an opinion: Q.    Dr. Wiley, taking the two vials,    which I understand you examined about six weeks after the shipment in question here, from your knowledge of sterile solutions and from your observation of sterile solutions, your experience, are you able to express an opinion to this court as to whether or not the contents of those two vials,    did contain the undissolved particles you noticed there then as of the date they were shipped, namely, on or about June 18, 1946? Your answer is yes or no. A. Yes.